Kentaro Takayama Selected Research

Esters

10/2017

Structure-Activity Relationship Study of Leucyl-3-epi-deoxynegamycin for Potent Premature Termination Codon Readthrough.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Takayama Research Topics

Disease

7	Neoplasms (Cancer) 10/2022 - 04/2010
6	Muscular Dystrophies (Muscular Dystrophy) 02/2023 - 04/2016
5	Obesity 03/2024 - 11/2016
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2023 - 02/2015
3	Body Weight (Weight, Body) 03/2024 - 08/2011
3	Cachexia 10/2022 - 04/2016
3	Muscular Atrophy (Muscle Atrophy) 03/2022 - 01/2015
3	Glioma (Gliomas) 01/2014 - 09/2009
2	Sarcopenia 03/2023 - 04/2016
2	Phototoxic Dermatitis (Phototoxicity) 02/2023 - 01/2021
2	Colitis 01/2022 - 01/2022
1	Rhabdomyolysis 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Crush Syndrome 01/2023
1	Wasting Syndrome (Wasting Disease) 10/2022
1	Atrophy 10/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Muscle Weakness 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2017
1	Heart Failure 09/2015
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2010

Drug/Important Bio-Agent (IBA)

14	MyostatinIBA 03/2023 - 01/2015
14	Peptides (Polypeptides)IBA 03/2023 - 09/2009
3	neuromedin UIBA 01/2020 - 11/2016
3	Nonsense Codon (Nonsense Mutation)IBA 10/2019 - 06/2015
2	neuromedin U receptorIBA 03/2024 - 01/2020
2	HydrazinesIBA 12/2023 - 06/2015
2	negamycinIBA 12/2023 - 06/2015
2	DystrophinIBA 12/2023 - 06/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 06/2015
2	Amino Acids FDA Link 10/2022 - 10/2019
2	SolutionsIBA 01/2022 - 01/2022
2	Dextran SulfateIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 04/2010
2	Messenger RNA (mRNA)IBA 09/2015 - 08/2011
2	Arginine (L-Arginine)FDA Link 04/2010 - 09/2009
1	CholesterolIBA 02/2024
1	Bile Acids and Salts (Bile Acids)IBA 02/2024
1	LipidsIBA 02/2024
1	DipeptidesIBA 12/2023
1	Inosine Triphosphate (ITP)IBA 03/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2022
1	Ghrelin ReceptorsIBA 10/2022
1	anamorelinIBA 10/2022
1	MagnesiumIBA 01/2022
1	Magnesium Oxide (Magnesia)FDA Link 01/2022
1	Magnesium Chloride FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	BoronIBA 01/2020
1	Cell-Penetrating PeptidesIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	GadoliniumIBA 01/2020
1	EstersIBA 10/2017
1	pyroglutamyl-histidyl-glycineIBA 11/2016
1	ProdrugsIBA 07/2016
1	Immunoglobulin G (IgG)IBA 07/2016
1	Immunoconjugates (Immunoconjugate)IBA 07/2016
1	NPI 2358IBA 07/2016
1	FurinIBA 09/2015
1	CaveolinsIBA 01/2015
1	polyarginineIBA 01/2014
1	Small Interfering RNA (siRNA)IBA 08/2011
1	AcidsIBA 04/2010
1	Protein SIBA 04/2010

Therapy/Procedure

3	Therapeutics 10/2022 - 04/2010
1	Intranasal Administration 03/2024
1	Renal Dialysis (Hemodialysis) 01/2023
1	Critical Care (Surgical Intensive Care) 01/2023
1	Boron Neutron Capture Therapy 01/2020
1	Intramuscular Injections 01/2015
1	Drug Therapy (Chemotherapy) 12/2012